Psomagen Reviews

1.9

10% would recommend to a friend

(31 total reviews)

9% positive business outlook

Psomagen has an employee rating of 1.9 out of 5 stars, based on 31 company reviews on Glassdoor which indicates that most employees have a poor working experience there. The Psomagen employee rating is 46% below average for employers within the Pharmaceutical and biotechnology industry (3.5 stars).

Reviews by job title

31 reviews
2.0
3 July 2026

Supportive management but high stress and miscommunication

Anonymous employee
Recommend
CEO approval
Business outlook

Pros

-Understanding with personal issues and accommodating with taking days off -Manager challenges you to figure out solutions and make you learn new ways of thinking -Supportive in training

Cons

-Many stress related tasks -Miscommunication from team members, not directly answering questions -Always directing U.S. employees to the “figure it out -c

1.0
3 Dec 2025
Recommend
CEO approval
Business outlook

Pros

the company provides insurance and visa support, and it can be a decent place to gain experience right after college. Some departments are fairly close-knit, depending on where you end up.

Cons

I’m not sure whether it’s the turnover rate or the firing rate, but either way, it is extremely high. Salaries are far below industry standards, and the overall atmosphere is tense to the point where people barely have any emotional space for each other. The work environment often feels hostile and emotionally aggressive, and even small issues can quickly turn into major conflicts. It is mentally exhausting on a daily basis. There is almost no structure, no clear workflow, and barely any proper onboarding. The culture is essentially “figure it out yourself,” and if you expect guidance or an American-style communication flow, you will run into constant value conflicts. As a Korean-owned company operating in the U.S., it carries over many typical Korean corporate problems—office politics, hierarchy, and unnecessary rigidity. People are often pressured, directly or indirectly, until they eventually leave on their own. The environment can be psychologically harsh and draining. On your first day, look at your senior’s face. If they don’t look happy, that’s most likely what your own future will look like. Many employees join hoping to get their visa. the environment is simply too toxic to endure long-term. If you truly have strong skills or potential, there is very little reason to stay here for this level of pay and stress. Most employees already know this.

1.0
14 Aug 2025
Recommend
CEO approval
Business outlook

Pros

You get a 1-hour lunch Allows for longer vacations Finally did a office refresh (was needed) Good for people looking to gain experience and move on.

Cons

There are zero meaningful Human Resource programs - Continued learning is discouraged as the lab needs everyone available all the time. No one gets to go to conferences or workshops to learn new techniques. The company didn't roll down company goals and personal objectives for 2024 (and 2025 from what I heard) and generally has no interest in personnel improvement and career planning. The lab management purchases new equipment but never installs them properly. They rarely buy the install/operation/performance qualification services because they cost extra, even though they perform clinical work and should be doing so. In the case of lab automation we bought lab management doesn't make it a priority to install and test protocols so most of the work is still done manually. Quality Assurance is a low priority, where profit is more important. Official company protocols are nonexistent, they use vendor handbooks and process decisions/guidance don't exist leading to a lot of redone work. Management hires people they can afford, not the right people for the role/job. Mngt/HR make employees clean the office since they are too cheap to hire a cleaning company. CFO and CEO continue to spend less on sales and marketing and simply hope new customers will show up. Other than the 3 Korean members of the sales team that have been there several years, that dept turns over every 1.5-2.5 years due to their frustration or CEO and CFO not seeing revenue improve - though they don't spend the money to gain more customers. 2024 was a nightmare as they brought in a new Chief Science Officer who didn't deliver and was incredibly rude to people. They tried to improve the clinical business but were never willing to invest in the change that was required and the VP left in 1 yr. Prior to Dec 2024 when Macrogen became 51% stakeholder, the mngt team was still being ruled by Macrogen who is on the other side of globe and disconnected from the US customers. And the 51% ownership may change company's ability to go after certain federal contracts as a US company that is now a majority owned by a foreign entity.

Viewing 1 - 3 of 31 Reviews

Glassdoor has 32 Psomagen reviews submitted anonymously by Psomagen employees. Read employee reviews and ratings on Glassdoor to decide if Psomagen is right for you.